SEASTAR MEDICAL HOLDING CORP (ICU) Stock Price & Overview
NASDAQ:ICU • US81256L3024
Current stock price
The current stock price of ICU is 4.31 USD. Today ICU is up by 21.07%. In the past month the price increased by 67.05%. In the past year, price decreased by -68.99%.
ICU Key Statistics
- Market Cap
- 15.516M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -8.30
- Dividend Yield
- N/A
ICU Stock Performance
ICU Stock Chart
ICU Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ICU. When comparing the yearly performance of all stocks, ICU is a bad performer in the overall market: 71.33% of all stocks are doing better.
ICU Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ICU. While ICU seems to be doing ok healthwise, there are quite some concerns on its profitability.
ICU Earnings
On March 25, 2026 ICU reported an EPS of -0.8 and a revenue of 420.00K. The company beat EPS expectations (25.28% surprise) and beat revenue expectations (11.64% surprise).
ICU Forecast & Estimates
5 analysts have analysed ICU and the average price target is 9.18 USD. This implies a price increase of 112.99% is expected in the next year compared to the current price of 4.31.
For the next year, analysts expect an EPS growth of 59.54% and a revenue growth 54.99% for ICU
ICU Groups
Sector & Classification
ICU Financial Highlights
Over the last trailing twelve months ICU reported a non-GAAP Earnings per Share(EPS) of -8.3. The EPS increased by 89.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.82% | ||
| ROE | -116.65% | ||
| Debt/Equity | 0 |
ICU Ownership
ICU Latest News, Press Relases and Analysis
ICU Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ICU
Company Profile
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, Colorado and currently employs 19 full-time employees. The company went IPO on 2021-01-26. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. The company has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Company Info
IPO: 2021-01-26
SEASTAR MEDICAL HOLDING CORP
3513 Brighton Blvd, Suite 410
Denver COLORADO US
Employees: 19
Phone: 18444278100
SEASTAR MEDICAL HOLDING CORP / ICU FAQ
Can you describe the business of SEASTAR MEDICAL HOLDING CORP?
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, Colorado and currently employs 19 full-time employees. The company went IPO on 2021-01-26. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. The company has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Can you provide the latest stock price for SEASTAR MEDICAL HOLDING CORP?
The current stock price of ICU is 4.31 USD. The price increased by 21.07% in the last trading session.
What is the dividend status of SEASTAR MEDICAL HOLDING CORP?
ICU does not pay a dividend.
What is the ChartMill rating of SEASTAR MEDICAL HOLDING CORP stock?
ICU has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is ICU stock listed?
ICU stock is listed on the Nasdaq exchange.
What do analysts say about SEASTAR MEDICAL HOLDING CORP (ICU) stock?
5 analysts have analysed ICU and the average price target is 9.18 USD. This implies a price increase of 112.99% is expected in the next year compared to the current price of 4.31.
What is the ownership structure of SEASTAR MEDICAL HOLDING CORP (ICU)?
You can find the ownership structure of SEASTAR MEDICAL HOLDING CORP (ICU) on the Ownership tab.